cholest-5-ene-3β,7α-diol 3β-dehydrogenase | |
Ec Number: | 1.1.1.181 |
Cas Number: | 56626-16-5 |
Go Code: | 0047016 |
hydroxy-Δ-5-steroid dehydrogenase, 3β- and steroid Δ-isomerase 7 | |
Hgncid: | 18324 |
Symbol: | HSD3B7 |
Entrezgene: | 80270 |
Omim: | 607764 |
Refseq: | NM_025193 |
Uniprot: | Q9H2F3 |
Ecnumber: | 1.1.1.181 |
Chromosome: | 16 |
Arm: | p |
Band: | 11.2 |
In enzymology, a cholest-5-ene-3β,7α-diol 3β-dehydrogenase is an enzyme that catalyzes the chemical reaction[1]
cholest-5-ene-3β,7α-diol + NAD+
\rightleftharpoons
Thus, the two substrates of this enzyme are cholest-5-ene-3β,7α-diol and NAD+, whereas its 3 products are 7α-hydroxycholest-4-en-3-one, NADH, and H+.
The systematic name of this enzyme class is cholest-5-ene-3β,7α-diol:NAD+ 3-oxidoreductase. This enzyme is also called 3β-hydroxy-Δ5-C27-steroid oxidoreductase. The human version of this enzyme is known as hydroxy-Δ-5-steroid dehydrogenase, 3 β- and steroid delta-isomerase 7 or HSD3B7 which is encoded by the HSD3B7 gene.[2] [3]
This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-OH group of donor with NAD+ or NADP+ as acceptor. This enzyme is involved in the initial stages of the synthesis of bile acids from cholesterol and a member of the short-chain dehydrogenase/reductase superfamily. This enzyme is a membrane-associated endoplasmic reticulum protein which is active against 7-alpha hydrosylated sterol substrates.
Mutations in the HSD3B7 gene are associated with a congenital bile acid synthesis defect which leads to neonatal cholestasis, a form of progressive liver disease.[4]